TSXgroup

April 23, 2008

AURICLE BIOMEDICAL CORPORATION ("AUB.P")
BULLETIN TYPE: New Listing-CPC-Shares
BULLETIN DATE: April 23, 2008
TSX Venture Tier 2 Company

This Capital Pool Company's ('CPC') Prospectus dated January 28, 2008 has been filed with and accepted by TSX Venture Exchange and the British Columbia and Alberta Securities Commissions effective January 31, 2008, pursuant to the provisions of the British Columbia and Alberta Securities Acts. The Common Shares of the Company will be listed on TSX Venture Exchange on the effective date stated below.

The Company has completed its initial distribution of securities to the public. The gross proceeds received by the Company for the Offering were $200,000 (2,000,000 common shares at $0.10 per share).

Commence Date: At the opening April 24, 2008, the Common shares will commence trading on TSX Venture Exchange.

Corporate Jurisdiction: British Columbia

Capitalization: unlimited common shares with no par value of which 4,900,000 common shares are issued and outstanding.
Escrowed Shares: 2,900,000 common shares

Transfer Agent: Pacific Corporate Trust Company
Trading Symbol: AUB.P
CUSIP Number: 05156L 10 4
Sponsoring Member: Canaccord Capital Corporation

Agent's Options: 200,000 non-transferable stock options. One option to purchase one share at $0.10 per share up to 24 months.

For further information, please refer to the Company's Prospectus dated January 28, 2008.

Company Contact: Punit Dhillon
Company Address: #208-5455 West Boulevard, Vancouver, BC V6M 3W5

Company Phone Number: (604) 263-8877
Company Fax Number: (858) 777-5481
Company Email Address: info@auriclebiomedical.com